NU-GREENS MULTI-VITAMIN
Natural health product licensed in Canada
- Licence holder
- Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
- NPN or DIN-HM
- 80041156
- Status
- Inactive licence
- Licence date
- 20 March 2013
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Citrate de calcium | 500 mg | Not calculated |
| Triticum aestivum Source : Herbe(s) | 386 mg | Not calculated |
| Glycine max Source : Germe(s) | 383 mg | Not calculated |
| Chlorella vulgaris Source : Cellule brisée | 383 mg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 200 mcg | Not calculated |
| Vitamine A Source : Palmitate de rétinyle tout trans Potency : 3,500 UI | 1,057 mcg EAR | Not calculated |
| Oryza sativa Source : Graine(s) | 383 mg | Not calculated |
| Iode Source : Bladderwrack - thallus | 100 mcg | Not calculated |
| Glycyrrhiza glabra Source : Root (standardized extract) Potency : 10 % Glycyrrhizic acid | 116 mg | Not calculated |
| Hordeum vulgare Source : Herbe(s) | 386 mg | Not calculated |
| Medicago sativa Source : Sommité | 386 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit (standardized extract) Extraction ratio : 100:1 Dry plant equivalent : 1,000 mg Potency : 25 % Anthocyanidins | 10 mg | Not calculated |
| Ginkgo biloba Source : leaf standardized extract Extraction ratio : 50:1 Dry plant equivalent : 1,000 mg Potency : 24 % Flavone | 20 mg | Not calculated |
| pollen d'abeille Source : various flowers | 150 mg | Not calculated |
| Biotine | 50 mcg | Not calculated |
| Silybum marianum Source : Seed (standardized extract) Potency : 80 % Silymarin | 60 mg | Not calculated |
| Molybdène Source : Produit de chélation de molybdène et de protéine végétale hydrolysée (PVH) | 25 mcg | Not calculated |
| Eleutherococcus senticosus Source : Root (standardized extract) Potency : 0.8 % Eleutherosides | 75 mg | Not calculated |
Non-medicinal ingredients
D-Malic acid, Feuille de stevia rebaudiana, Saveur, Acid citrique, Berry flavour, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision. A factor in the maintenance of good health. Helps the body to metabolize fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. Helps normal growth. Helps in tissue formation. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.Helps to produce red blood cells. Helps in the development and maintenance of bones and teeth, (especially in childhood, adolescence and young adulthood). Helps to maintain proper muscle function. Helps to maintain healthy skin. Helps to maintain immune function. Provides support for healthy glucose metabolism. Source of antioxidants to reduce oxidative stress/damage for the maintenance of good health. Helps normal growth and development. Helps in the function of the thyroid gland.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80041156
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.